Literature DB >> 8289387

Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells.

K S Dingwell1, C R Brunetti, R L Hendricks, Q Tang, M Tang, A J Rainbow, D C Johnson.   

Abstract

Herpes simplex virus (HSV) glycoproteins E and I (gE and gI) can act as a receptor for the Fc domain of immunoglobulin G (IgG). To examine the role of HSV IgG Fc receptor in viral pathogenesis, rabbits and mice were infected by the corneal route with HSV gE- or gI- mutants. Wild-type HSV-1 produced large dendritic lesions in the corneal epithelium and subsequent stromal disease leading to viral encephalitis, whereas gE- and gI- mutant viruses produced microscopic punctate or small dendritic lesions in the epithelium and no corneal disease or encephalitis. These differences were not related to the ability of the gE-gI oligomer to bind IgG because the differences were observed before the appearance of anti-HSV IgG and in mice, in which IgG binds to the Fc receptor poorly or not at all. Mutant viruses produced small plaques on monolayers of normal human fibroblasts and epithelial cells. Replication of gE- and gI- mutant viruses in human fibroblasts were normal, and the rates of entry of mutant and wild-type viruses into fibroblasts were similar; however, spread of gE- and gI- mutant viruses from cell to cell was significantly slower than that of wild-type HSV-1. In experiments in which fibroblast monolayers were infected with low multiplicities of virus and multiple rounds of infection occurred, the presence of neutralizing antibodies in the culture medium caused the yields of mutant viruses to drop dramatically, whereas there was a lesser effect on the production of wild-type HSV. It appears that cell-to-cell transmission of wild-type HSV-1 occurs by at least two mechanisms: (i) release of virus from cells and entry of extracellular virus into a neighboring cell and (ii) transfer of virus across cell junctions in a manner resistant to neutralizing antibodies. Our results suggest that gE- and gI- mutants are defective in the latter mechanism of spread, suggesting the possibility that the gE-gI complex facilitates virus transfer across cell junctions, a mode of spread which may predominate in some tissues. It is ironic that the gE-gI complex, usually considered an IgG Fc receptor, may, through its ability to mediate cell-to-cell spread, actually protect HSV from IgG in a manner different than previously thought.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289387      PMCID: PMC236520          DOI: 10.1128/JVI.68.2.834-845.1994

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Glycoprotein gI of pseudorabies virus promotes cell fusion and virus spread via direct cell-to-cell transmission.

Authors:  L Zsak; F Zuckermann; N Sugg; T Ben-Porat
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  The UL10 gene of herpes simplex virus 1 encodes a novel viral glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells.

Authors:  J D Baines; B Roizman
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

3.  Envelope glycoprotein gp50 of pseudorabies virus is essential for virus entry but is not required for viral spread in mice.

Authors:  B Peeters; J Pol; A Gielkens; R Moormann
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

4.  IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice.

Authors:  R L Hendricks; T M Tumpey; A Finnegan
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

5.  A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H.

Authors:  C Roop; L Hutchinson; D C Johnson
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

6.  The ICP4 binding sites in the herpes simplex virus type 1 glycoprotein D (gD) promoter are not essential for efficient gD transcription during virus infection.

Authors:  J R Smiley; D C Johnson; L I Pizer; R D Everett
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Antistasin, an inhibitor of coagulation and metastasis, binds to sulfatide (Gal(3-SO4) beta 1-1Cer) and has a sequence homology with other proteins that bind sulfated glycoconjugates.

Authors:  G D Holt; H C Krivan; G J Gasic; V Ginsburg
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

8.  Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI.

Authors:  V Litwin; W Jackson; C Grose
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

9.  Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system.

Authors:  J P Card; M E Whealy; A K Robbins; L W Enquist
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

10.  Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.

Authors:  R L Hendricks; M Janowicz; T M Tumpey
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

View more
  169 in total

1.  Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  The extracellular domain of herpes simplex virus gE is sufficient for accumulation at cell junctions but not for cell-to-cell spread.

Authors:  T Wisner; C Brunetti; K Dingwell; D C Johnson
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Mutations in herpes simplex virus glycoprotein D distinguish entry of free virus from cell-cell spread.

Authors:  D A Rauch; N Rodriguez; R J Roller
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease.

Authors:  C E Saldanha; J Lubinski; C Martin; T Nagashunmugam; L Wang; H van Der Keyl; R Tal-Singer; H M Friedman
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 5.  Directed egress of animal viruses promotes cell-to-cell spread.

Authors:  David C Johnson; Mary T Huber
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  Cytoplasmic domain of herpes simplex virus gE causes accumulation in the trans-Golgi network, a site of virus envelopment and sorting of virions to cell junctions.

Authors:  T N McMillan; D C Johnson
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 7.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

8.  Characterization of a BHK(TK-) cell clone resistant to postattachment entry by herpes simplex virus types 1 and 2.

Authors:  R J Roller; B C Herold
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  The gE and gI homologs from two alphaherpesviruses have conserved and divergent neuroinvasive properties.

Authors:  A C Knapp; P J Husak; L W Enquist
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

10.  The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection.

Authors:  Mir A Ali; Qingxue Li; Elizabeth R Fischer; Jeffrey I Cohen
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.